Medline lands $30B private equity investment: 5 details

Medline, a large, privately held manufacturer and distributor of healthcare supplies, received a multibillion-dollar investment to expand international growth.

Five details:

1. Three private equity firms, Blackstone, Carlyle and Hellman & Friedman, partnered with Singapore's sovereign wealth fund GIC for a majority investment in Medline, the companies announced June 5.

2. The transaction, valued at more than $30 billion according to The Wall Street Journal, is expected to close in late 2021.

3. In 2020, Medline reported $17.5 billion in revenue and the company plans to use the new funds to expand product offerings, grow faster internationally and invest in global supply chain infrastructure.

4. Post-transaction, the Mills family will still be the largest single shareholder and Medline will remain a privately held, family-led company. The senior management team is staying entact.

5. This investment in Medline is the largest leveraged buyout in more than 10 years, according to the Journal.

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Whitepapers

Featured Webinars